vancomycin has been researched along with Flavobacteriaceae Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Ajithkumar, VT; Geeta, MG; Krishnan, C; Raj, A; Rajesh, TV; Shabina, MPB | 1 |
| Kheng, C; Ling, CL; Miliya, T; Reed, TAN; Roberts, T; Tan, P; Turner, P; Watson, G | 1 |
| Almuwallad, OK; Barnawi, AI; Kassarah, KA; Kordy, FN | 1 |
| Hsieh, TC; Hsueh, PR; Jean, SS; Ning, YZ | 1 |
| Heidari, H; Khashei, R; Nabavizadeh, SH; Sedigh Ebrahim-Saraie, H | 1 |
| Joshi, P; Joshi, V; Kumar, A; Shah, B; Singhal, T | 1 |
| Chang, TY; Chen, HY; Cheng, YH; Chou, YC; Sun, JR | 1 |
| Jhanji, V; Li, EY | 1 |
| Bayrak, B; Bınay, UD; Çımen, C; Fıncanci, M; Özkantar Ünlügüneş, GU | 1 |
| Agrawal, U; Desai, K; Shetty, A; Soman, R; Suthar, M | 1 |
| Palasuntheram, C; Perera, S | 1 |
| Agus, N; Anil, M; Helvaci, M; Ozkalay, N; Sirti, S | 1 |
| Kitiyakara, C; Likittanasombat, K; Lothuvachai, T; Milindankura, S; Sakulsaengprapha, A | 1 |
1 review(s) available for vancomycin and Flavobacteriaceae Infections
| Article | Year |
|---|---|
Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Immunocompromised Host; Infant, Low Birth Weight; Infant, Newborn; Linezolid; Meningitis, Bacterial; Rifampin; Treatment Outcome; Vancomycin | 2017 |
12 other study(ies) available for vancomycin and Flavobacteriaceae Infections
| Article | Year |
|---|---|
Topics: Anti-Bacterial Agents; Child; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Piperacillin; Vancomycin | 2023 |
Elizabethkingia anophelis Infection in Infants, Cambodia, 2012-2018.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Vancomycin | 2020 |
Early neonatal sepsis and meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Rifampin; Saudi Arabia; Sepsis; Treatment Outcome; Vancomycin | 2020 |
A rare case of complicated pericardial effusion with Elizabethkingia meningoseptica from Iran.
Topics: Anti-Bacterial Agents; Child, Preschool; Chryseobacterium; Flavobacteriaceae Infections; Humans; Lymphangioleiomyomatosis; Male; Pericardial Effusion; Vancomycin | 2018 |
Treatment of Elizabethkingia meningoseptica Neonatal Meningitis with Combination Systemic and Intraventricular Therapy.
Topics: Anti-Bacterial Agents; Brain; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Intravenous; Infusions, Intraventricular; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Neuroimaging; Vancomycin; Ventriculoperitoneal Shunt | 2019 |
In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Edetic Acid; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Rifampin; Species Specificity; Vancomycin | 2019 |
Massive lipid keratopathy after Elizabethkingia meningosepticum keratitis.
Topics: Anti-Bacterial Agents; Corneal Diseases; Corneal Ulcer; Eye Infections, Bacterial; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Lipid Metabolism Disorders; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Vancomycin | 2014 |
[Elizabethkingia meningosepticum bacteremia in a patient with Bardet-Biedl syndrome and chronic renal failure].
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bardet-Biedl Syndrome; Catheter-Related Infections; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Kidney Failure, Chronic; Male; Vancomycin | 2014 |
Successful Management of Elizabethkingia meningoseptica Meningitis with Intraventricular Vancomycin.
Topics: Aged; Anti-Bacterial Agents; Chryseobacterium; Flavobacteriaceae Infections; Humans; Infusions, Intraventricular; Male; Meningitis, Bacterial; Remission Induction; Vancomycin | 2016 |
Chryseobacterium meningosepticum infections in a dialysis unit.
Topics: Chryseobacterium; Ciprofloxacin; Cross Infection; Equipment Contamination; Flavobacteriaceae Infections; Hemodialysis Units, Hospital; Hospitals, General; Hospitals, Teaching; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Sepsis; Sri Lanka; Vancomycin | 2004 |
Community-acquired meningitis and sepsis caused by Chryseobacterium meningosepticum in a patient diagnosed with thalassemia major.
Topics: Adolescent; Anti-Bacterial Agents; beta-Thalassemia; Chryseobacterium; Community-Acquired Infections; Flavobacteriaceae Infections; Humans; Male; Meningitis, Bacterial; Sepsis; Vancomycin | 2006 |
Chryseobacterium meningosepticum infection and cardiac tamponade in a long-term hemodialysis patient.
Topics: Aged; Anti-Bacterial Agents; Cardiac Tamponade; Chryseobacterium; Ciprofloxacin; Fatal Outcome; Flavobacteriaceae Infections; Humans; Kidney Failure, Chronic; Male; Meropenem; Pericarditis; Renal Dialysis; Thienamycins; Vancomycin | 2006 |